Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $152000.0.

  • Bio's Other Non Operating Income fell 5489.61% to $152000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 3067.45%. This contributed to the annual value of $1.4 million for FY2024, which is 4608.96% down from last year.
  • According to the latest figures from Q3 2025, Bio's Other Non Operating Income is $152000.0, which was down 5489.61% from $379000.0 recorded in Q2 2025.
  • Over the past 5 years, Bio's Other Non Operating Income peaked at $870000.0 during Q2 2023, and registered a low of -$1.2 million during Q2 2022.
  • For the 5-year period, Bio's Other Non Operating Income averaged around $183666.7, with its median value being $293000.0 (2024).
  • Its Other Non Operating Income has fluctuated over the past 5 years, first tumbled by 143500.0% in 2022, then surged by 54205.61% in 2023.
  • Quarter analysis of 5 years shows Bio's Other Non Operating Income stood at -$43000.0 in 2021, then plummeted by 353.49% to -$195000.0 in 2022, then skyrocketed by 475.9% to $733000.0 in 2023, then tumbled by 61.12% to $285000.0 in 2024, then tumbled by 46.67% to $152000.0 in 2025.
  • Its last three reported values are $152000.0 in Q3 2025, $379000.0 for Q2 2025, and $479000.0 during Q1 2025.